Drug-like chelating agents: a potential lead for Alzheimer's disease
Authors:
- 9 October 2014
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 4 (94) , 52088-52099
Abstract
Recent evidence has indicated that dyshomeostasis of biometals (Fe, Cu, Zn) in the brain might contributes to the pathogenesis of Alzheimer's disease (AD). Experiments have also found that the level of metal ions in AD patients was 3–7 fold higher than that of healthy individuals. Many drug-like chelating agents were found to be able to reverse Aβ aggregation, dissolve amyloid plaques and delay the AD-related cognitive impairment. This review systematically discusses the drug-like chelating agents for AD as well as their potential applications in the future.Keywords
Funding Information
- National Natural Science Foundation of China (81302646)
This publication has 134 references indexed in Scilit:
- Exploring the multifunctionality of thioflavin- and deferiprone-based molecules as acetylcholinesterase inhibitors for potential application in Alzheimer's diseaseMolecular BioSystems, 2013
- Multitarget-Directed Benzylideneindanone Derivatives: Anti-β-Amyloid (Aβ) Aggregation, Antioxidant, Metal Chelation, and Monoamine Oxidase B (MAO-B) Inhibition Properties against Alzheimer’s DiseaseJournal of Medicinal Chemistry, 2012
- Role of metal dyshomeostasis in Alzheimer's diseaseMetallomics, 2011
- Synthesis and spectroscopic characterization of new tetradentate Schiff base and its coordination compounds of NOON donor atoms and their antibacterial and antifungal activityArabian Journal of Chemistry, 2010
- A Prochelator Activated by β-Secretase Inhibits Aβ Aggregation and Suppresses Copper-Induced Reactive Oxygen Species FormationJournal of the American Chemical Society, 2010
- A Prochelator Activated by Hydrogen Peroxide Prevents Metal‐Induced Amyloid β AggregationChemBioChem, 2009
- Small Molecule Modulators of Copper-Induced Aβ AggregationJournal of the American Chemical Society, 2009
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006
- Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer?s A? peptidesJBIC Journal of Biological Inorganic Chemistry, 2004
- Oxidative damage in Alzheimer'sNature, 1996